Literature DB >> 14962685

Assessment of the nutrition status of patients with Huntington's disease.

Araceli Trejo1, Rosa María Tarrats, Ma Elisa Alonso, Marie-Catherine Boll, Adriana Ochoa, Leora Velásquez.   

Abstract

OBJECTIVE: The purpose of the present study was to compare the nutrition status of patients with Huntington's disease (HD) with that of control subjects by analyzing anthropometric and biochemical indicators, energy, and macronutrient intake and to determine which indicators are most altered in HD patients.
METHODS: We assessed the nutrition status of 25 HD patients and 25 age- and sex-matched controls by measuring anthropometric and biochemical indicators. Food intake data were obtained by the 3-d record method to assess mean daily energy and macronutrient intake. We studied variables reported by the patients such as increased or decreased appetite, mastication difficulties, and solid food and liquid food dysphagia. A neurologist assessed the clinical features of HD patients by using the Unified Huntington's Disease Rating Scale.
RESULTS: HD patients showed significantly lower anthropometric variables but significantly higher kilocalorie intake. Among the subjective variables analyzed, patient-referred weight loss, increased appetite, mastication, and solid food dysphagia were significantly more frequent in HD patients than in controls. We also found relations between motor disability and some anthropometric parameters in HD patients. In particular, we found a significant correlation between total motor disability score and body mass index and arm muscle circumference (r = -0.464 and -0.445, respectively; P < 0.05) and with percentage of body fat (r = -0.496, P = 0.012).
CONCLUSIONS: It is of the utmost importance to identify nutritional alterations in HD patients and to find strategies to cover their kilocalorie and nutrient requirements to improve their quality of life.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962685     DOI: 10.1016/j.nut.2003.10.007

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  45 in total

Review 1.  Therapy in Huntington's disease: where are we?

Authors:  Martha A Nance
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  Hypocretin-1 (orexin A) levels are normal in Huntington's disease.

Authors:  Christian R Baumann; Martin Hersberger; Claudio L Bassetti
Journal:  J Neurol       Date:  2006-04-05       Impact factor: 4.849

Review 3.  Energy deficit in Huntington disease: why it matters.

Authors:  Fanny Mochel; Ronald G Haller
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

4.  Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice.

Authors:  Brett D Dufour; Catherine A Smith; Randall L Clark; Timothy R Walker; Jodi L McBride
Journal:  Mol Ther       Date:  2014-01-06       Impact factor: 11.454

5.  Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.

Authors:  Karen Marder; Yian Gu; Shirley Eberly; Caroline M Tanner; Nikolaos Scarmeas; David Oakes; Ira Shoulson
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

6.  Measures of growth in children at risk for Huntington disease.

Authors:  Jessica K Lee; Kathy Mathews; Bradley Schlaggar; Joel Perlmutter; Jane S Paulsen; Eric Epping; Leon Burmeister; Peg Nopoulos
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

7.  Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.

Authors:  Renee R Handley; Suzanne J Reid; Rudiger Brauning; Paul Maclean; Emily R Mears; Imche Fourie; Stefano Patassini; Garth J S Cooper; Skye R Rudiger; Clive J McLaughlan; Paul J Verma; James F Gusella; Marcy E MacDonald; Henry J Waldvogel; C Simon Bawden; Richard L M Faull; Russell G Snell
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

Review 8.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

9.  Upper gastrointestinal findings in Huntington's disease: patients suffer but do not complain.

Authors:  Jürgen E Andrich; Michael Wobben; Peter Klotz; Oliver Goetze; Carsten Saft
Journal:  J Neural Transm (Vienna)       Date:  2009-09-22       Impact factor: 3.575

10.  Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression.

Authors:  Mahmoud A Pouladi; Yuanyun Xie; Niels Henning Skotte; Dagmar E Ehrnhoefer; Rona K Graham; Jeong Eun Kim; Nagat Bissada; X William Yang; Paolo Paganetti; Robert M Friedlander; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2010-01-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.